X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761051
http://www.pharmafile.com/news/595265/nice-recommends-mogamulizumab-treatment-ultra-rare-blood-cancers
http://www.pharmatimes.com/news/nice_to_reassess_kyowa_kirins_poteligeo_1371577
http://www.pharmatimes.com/news/nice_rejects_nhs_funding_for_kyowa_kirins_poteligeo_1345979
https://www.pharmiweb.com/press-release/2020-06-17/kyowa-kirin-makes-poteligeo-mogamulizumab-available-in-europe-for-the-treatment-of-mycosis-fungoides-and-s%C3%A9zary-syndrome-two-rare-forms-of-non-hod
https://www.ema.europa.eu/documents/overview/poteligeo-epar-medicine-overview_en.pdf
http://www.pharmatimes.com/news/chmp_puts_13_therapies_forward_for_eu_approval_1253165
http://www.prnewswire.co.uk/news-releases/kyowa-kirin-announces-mogamulizumab-received-positive-chmp-opinion-for-the-treatment-of-mycosis-693929631.html
https://www.raps.org/news-and-articles/news-articles/2018/9/chmp-backs-13-new-medicines-maintains-negative-op?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%2021%20September
https://www.biospace.com/article/fda-approves-eight-novel-drugs-in-august-fd1a-/
https://www.biospace.com/article/releases/kyowa-hakko-kirin-announces-results-of-phase-3-clinical-study-of-mogamulizumab-published-in-lancet-oncology/
Market Place
Share 
